Use este identificador para citar ou linkar para este item:
https://www.arca.fiocruz.br/handle/icict/10870
Tipo de documento
ArtigoDireito Autoral
Acesso aberto
Coleções
- IOC - Artigos de Periódicos [12747]
Metadata
Mostrar registro completo
MULTIPLEX NUCLEIC ACID AMPLIFICATION TEST FOR DIAGNOSIS OF DENGUE FEVER, MALARIA, AND LEPTOSPIROSIS
Autor(es)
Afiliação
Stanford University School of Medicine. Department of Medicine. Division of Infectious Diseases and Geographic Medicine. Stanford, CA, USA.
Stanford University School of Medicine. Department of Pathology. Stanford, CA, USA.
Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de Zoonoses Bacterianas. WHO/PAHO Centro Colaborador para Leptospirose. Centro de Referência Nacional para Leptospirose. Coleção de Leptospira. Rio de Janeiro, RJ, Brasil.
Stanford University School of Medicine. Department of Pathology. Stanford, CA, USA.
Stanford University School of Medicine. Department of Pathology. Stanford, CA, USA.
Stanford University School of Medicine. Department of Pathology. Stanford, CA, USA.
Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de Zoonoses Bacterianas. WHO/PAHO Centro Colaborador para Leptospirose. Centro de Referência Nacional para Leptospirose. Coleção de Leptospira. Rio de Janeiro, RJ, Brasil.
Sustainable Sciences Institute. Managua, Nicaragua.
Ministry of Health. Centro Nacional de Diagnóstico y Referencia. National Virology Laboratory. Mnagua, Nicaragua.
University of California. School of Public Health. Division of Infectious Diseases and Vaccinology. Berkeley, CA, USA.
Stanford University School of Medicine. Department of Pathology. Stanford, CA, USA.
Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de Zoonoses Bacterianas. WHO/PAHO Centro Colaborador para Leptospirose. Centro de Referência Nacional para Leptospirose. Coleção de Leptospira. Rio de Janeiro, RJ, Brasil.
Stanford University School of Medicine. Department of Pathology. Stanford, CA, USA.
Stanford University School of Medicine. Department of Pathology. Stanford, CA, USA.
Stanford University School of Medicine. Department of Pathology. Stanford, CA, USA.
Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de Zoonoses Bacterianas. WHO/PAHO Centro Colaborador para Leptospirose. Centro de Referência Nacional para Leptospirose. Coleção de Leptospira. Rio de Janeiro, RJ, Brasil.
Sustainable Sciences Institute. Managua, Nicaragua.
Ministry of Health. Centro Nacional de Diagnóstico y Referencia. National Virology Laboratory. Mnagua, Nicaragua.
University of California. School of Public Health. Division of Infectious Diseases and Vaccinology. Berkeley, CA, USA.
Resumo em Inglês
Dengue, leptospirosis, and malaria are among the most common etiologies of systemic undifferentiated febrile illness (UFI)
among travelers to the developing world, and these pathogens all have the potential to cause life-threatening illness in returned
travelers. The current study describes the development of an internally controlled multiplex nucleic acid amplification test for
the detection of dengue virus (DENV) and Leptospira and Plasmodium species, with a specific callout for Plasmodium falciparum
(referred to as the UFI assay). During analytical evaluation, the UFI assay displayed a wide dynamic range and a sensitive
limit of detection for each target, including all four DENV serotypes. In a clinical evaluation including 210 previously tested
samples, the sensitivities of the UFI assay were 98% for DENV (58/59 samples detected) and 100% for Leptospira and malaria
(65/65 and 20/20 samples, respectively). Malaria samples included all five Plasmodium species known to cause human disease.
The specificity of the UFI assay was 100% when evaluated with a panel of 66 negative clinical samples. Furthermore, no amplification
was observed when extracted nucleic acids from related pathogens were tested. Compared with whole-blood samples, the
UFI assay remained positive for Plasmodium in 11 plasma samples from patients with malaria (parasitemia levels of 0.0037 to
3.4%). The syndrome-based design of the UFI assay, combined with the sensitivities of the component tests, represents a significant
improvement over the individual diagnostic tests available for these pathogens.
Compartilhar